Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/2168
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGerraty, Richard-
dc.date.accessioned2022-11-30T02:07:39Z-
dc.date.available2022-11-30T02:07:39Z-
dc.date.issued2021-07-
dc.identifier.citationBMJ Neurol Open . 2021 Jul 21;3(2):e000194en_US
dc.identifier.issn2044-6055en_US
dc.identifier.urihttp://hdl.handle.net/11434/2168-
dc.description.abstractCerebral microbleeds (CMBs) are commonly detected on routine MRIs of the brain in centres that incorporate a susceptibility sequence as standard. The susceptibility weighted imaging (SWI) sequence is increasingly available and is more sensitive than gradient echo in detection of small susceptibility abnormalities caused by iron from haemoglobin, occurring either as CMBs or cortical superficial siderosis, with the underlying diagnosis usually inferred to be cerebral amyloid angiopathy (CAA) for the more peripheral hemisphere location of CMBs. Cortical superficial siderosis is likely a more specific marker of CAA1 and in patients with cortico-subcortical CMBs alone, other causes should be considered.en_US
dc.publisherBMJ Publishing Groupen_US
dc.subjectMagnetic Resonance Imagingen_US
dc.subjectMRIen_US
dc.subjectAmyloiden_US
dc.subjectCerebrovascular Diseaseen_US
dc.subjectNeurosciences Clinical Institute, Epworth HealthCare, Victoria, Australiaen_US
dc.titleNot all cortical cerebral microbleeds are due to cerebral amyloid angiopathy.en_US
dc.typeJournal Articleen_US
dc.identifier.doi10.1136/bmjno-2021-000194.en_US
dc.identifier.journaltitleBMJ Openen_US
dc.description.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/35663369/en_US
dc.type.contenttypeTexten_US
Appears in Collections:Neurosciences

Files in This Item:
There are no files associated with this item.


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.